Wei-Ting Chang Selected Research

Indicators and Reagents (Reagents)

1/2023	Association of prognostic nutritional index with risk of contrast induced nephropathy: A meta-analysis.
10/2020	The Expression of MicroRNA-21 in Bone Marrow Fluid is an Indicator of Hematological Disorders and Mortality.
9/2016	Comparison of illegal drug use pattern in Taiwan and Korea from 2006 to 2014.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Ting Chang Research Topics

Disease

20	Neoplasms (Cancer) 01/2024 - 06/2011
17	Heart Failure 03/2024 - 05/2019
11	Cardiotoxicity 01/2024 - 09/2016
10	Breast Neoplasms (Breast Cancer) 01/2024 - 09/2016
10	Fibrosis (Cirrhosis) 11/2023 - 12/2016
7	Hypertension (High Blood Pressure) 01/2023 - 01/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2020
6	Hypertrophy 06/2023 - 11/2018
4	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 04/2015
4	Diabetes Mellitus 01/2024 - 03/2020
4	Myocardial Infarction 01/2023 - 11/2015
4	Hypoxia (Hypoxemia) 01/2022 - 11/2018
4	COVID-19 11/2021 - 12/2020
4	Cardiomegaly (Heart Hypertrophy) 01/2019 - 01/2017
3	Chronic Renal Insufficiency 03/2024 - 09/2022
3	ST Elevation Myocardial Infarction 01/2024 - 01/2017
3	Pulmonary Arterial Hypertension 12/2023 - 01/2021
3	Congenital Heart Defects (Congenital Heart Defect) 12/2023 - 12/2019
3	Mitral Valve Insufficiency (Mitral Regurgitation) 11/2023 - 01/2021
3	Acute Coronary Syndrome 11/2023 - 01/2017
3	Hemorrhage 09/2022 - 01/2020
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2022
3	Inflammation (Inflammations) 11/2021 - 01/2015
3	Pituitary Neoplasms (Pituitary Adenoma) 12/2020 - 11/2019
3	Thrombosis (Thrombus) 10/2020 - 01/2017
3	Hyperglycemia 01/2019 - 12/2016
2	Obesity 12/2023 - 10/2023
2	Kidney Diseases (Kidney Disease) 11/2023 - 01/2020
2	Atrial Fibrillation 01/2023 - 06/2021
2	Cardiac Arrhythmias (Arrythmia) 01/2023 - 01/2021
2	Ischemic Stroke 01/2023 - 09/2022
2	Lung Neoplasms (Lung Cancer) 01/2023 - 10/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2023
2	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 10/2021
2	Dyspnea (Shortness of Breath) 10/2022 - 09/2016
2	Thromboembolism 09/2022 - 01/2022
2	Venous Thromboembolism 09/2022 - 01/2021
2	Pulmonary Embolism 09/2022 - 04/2020
2	Pulmonary Hypertension 09/2022 - 12/2019
2	Hypersensitivity (Allergy) 11/2021 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2018
2	Myocarditis (Carditis) 01/2021 - 01/2021
2	Sarcoma (Soft Tissue Sarcoma) 11/2013 - 10/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2024
1	Liver Diseases (Liver Disease) 01/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Overweight 10/2023
1	Amyloidosis 07/2023
1	Restrictive Cardiomyopathy 07/2023

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2015
7	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2018
6	dapagliflozinIBA 11/2023 - 01/2021
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2019
5	AnticoagulantsIBA 01/2023 - 10/2019
4	AnthracyclinesIBA 01/2024 - 01/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024 - 01/2023
3	Trastuzumab (Herceptin)FDA Link 01/2024 - 12/2021
3	Cardiovascular AgentsIBA 01/2023 - 01/2022
3	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2016
3	Angiotensin Receptor AntagonistsIBA 05/2022 - 12/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2020
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2022 - 01/2022
3	CytokinesIBA 11/2021 - 01/2015
3	alpha-2-HS-GlycoproteinIBA 01/2017 - 04/2015
2	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 01/2022
2	Sodium-Glucose Transport ProteinsIBA 01/2024 - 01/2023
2	SodiumIBA 11/2023 - 12/2022
2	Vitamin K FDA Link 01/2023 - 09/2022
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2023
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2023
2	RivaroxabanIBA 09/2022 - 01/2021
2	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 01/2020
2	Angiotensin IIIBA 07/2022 - 01/2021
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2022 - 01/2021
2	Epirubicin (Ellence)FDA LinkGeneric 04/2022 - 09/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
2	Conditioned Culture MediaIBA 11/2021 - 11/2018
2	Insulin (Novolin)FDA Link 01/2021 - 01/2018
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 12/2016
2	LipidsIBA 03/2020 - 01/2018
2	CalcineurinIBA 01/2019 - 01/2019
2	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 11/2018 - 12/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2018 - 12/2016
2	Telmisartan (Micardis)FDA Link 01/2018 - 12/2016
2	VaccinesIBA 09/2015 - 06/2011
2	Arabinofuranosyluracil (Ara U)IBA 11/2013 - 10/2011
1	A-factor (Streptomyces)IBA 01/2024
1	Cytochrome P-450 CYP2C19IBA 12/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2023
1	MicroRNAs (MicroRNA)IBA 12/2023
1	Carvedilol (Coreg)FDA LinkGeneric 11/2023
1	IvabradineIBA 11/2023
1	Amyloid (Amyloid Fibrils)IBA 07/2023
1	Prealbumin (Transthyretin)IBA 07/2023

Therapy/Procedure

21	Therapeutics 01/2024 - 04/2013
6	Drug Therapy (Chemotherapy) 01/2023 - 09/2016
3	Percutaneous Coronary Intervention 01/2024 - 11/2015
2	Subacute Care 03/2024 - 05/2019
2	Length of Stay 01/2024 - 01/2013
2	Immunotherapy 09/2015 - 01/2013